| | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| 2025 | 2023 | MINNESOTA HEALTHSOLUTIONS CORPORATION | 861 E HENNEPIN AVE | MINNEAPOLIS | MN | 55414 | HENNEPIN | USA | Lung Diseases Research | 000 | 3 | 2/14/2025 | NON-COMPETING CONTINUATION | $0 |
|
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| 2024 | 2023 | MINNESOTA HEALTHSOLUTIONS CORPORATION | 861 E HENNEPIN AVE | MINNEAPOLIS | MN | 55414 | HENNEPIN | USA | Lung Diseases Research | 000 | 3 | 2/28/2024 | NON-COMPETING CONTINUATION | $0 |
|
 | Issue Date FY: 2023 ( Subtotal = $935,869 ) |
| 2023 | 2023 | MINNESOTA HEALTHSOLUTIONS CORPORATION | 861 E HENNEPIN AVE STE 440 | MINNEAPOLIS | MN | 55414 | HENNEPIN | USA | Lung Diseases Research | 001 | 3 | 2/1/2023 | NON-COMPETING CONTINUATION | $935,869 |
| 2023 | 2022 | MINNESOTA HEALTHSOLUTIONS CORPORATION | 861 E HENNEPIN AVE STE 440 | MINNEAPOLIS | MN | 55414 | HENNEPIN | USA | Lung Diseases Research | 000 | 2 | 10/20/2022 | COMPETING CONTINUATION | $0 |
|
 | Issue Date FY: 2022 ( Subtotal = $1,018,633 ) |
| 2022 | 2022 | MINNESOTA HEALTHSOLUTIONS CORPORATION | 861 E HENNEPIN AVE STE 440 | MINNEAPOLIS | MN | 55414 | HENNEPIN | USA | Lung Diseases Research | 000 | 2 | 2/17/2022 | COMPETING CONTINUATION | $1,018,633 |
|
|